Derya Sema Yaman Kalender

Derya Sema Yaman Kalender

Auto-generated profile, based on publicly available information

Derya Sema Yaman Kalender

Department of Biomedical Technologies, Institute of Natural and Applied Sciences, Izmir Katip Celebi University, Izmir, Türkiye

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2026 in Diabetology International
Verified
Journal Article
Closed access
DKDerya Sema Yaman Kalender
Derya Sema Yaman Kalender
ÜÇÜmit Çavdar
Ümit Çavdar
MEMehmet Sercan Ertürk
Mehmet Sercan Ertürk
BPBarış Önder Pamuk
Barış Önder Pamuk

30 December 2024 in Clinical Endocrinology
Verified
Journal Article
Closed access
ÜÇÜmit Çavdar
Ümit Çavdar
DKDerya Sema Yaman Kalender
Derya Sema Yaman Kalender
BYBerna Demir Yüksel
Berna Demir Yüksel
BPBarış Önder Pamuk
Barış Önder Pamuk
AÇAbdurrahman Çömlekçi
Abdurrahman Çömlekçi
SYSerkan Yener
Serkan Yener

10 September 2026 in Photobiomodulation, Photomedicine, and Laser Surgery
Verified
Journal Article
Closed access
DKDerya Sema Yaman Kalender
Derya Sema Yaman Kalender
MKMehmet Eren Kalender
Mehmet Eren Kalender
NTNermin Topaloğlu
Nermin Topaloğlu
Purpose: Among thyroid malignancies, papillary thyroid carcinoma (PTC) occurs most frequently, and therapeutic resistance remains a major obstacle in advanced disease. In this study, we evaluated the potential of pioglitazone (PIO), a peroxisome proliferator-activated receptor gamma agonist, to enhance the efficacy of indocyanine green (ICG)-mediated photodynamic therapy (PDT) in B-CPAP human PTC cells. Methods: After dose optimization, PIO and ICG were tested individually and in combination with laser irradiation (808 nm, 50 J/cm 2 ). The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) test was utilized to assess cell viability, while intracellular reactive oxygen species (ROS) generation and mitochondrial membrane potential (MMP) were examined to better elucidate the underlying mechanisms. Results: PIO alone showed minimal cytotoxicity in B-CPAP cells, whereas ICG–PDT induced a moderate reduction in viability. The combined treatment with 64.5 μM ICG and 509.0 μM PIO under PDT conditions significantly decreased cell survival to ∼50%, resulting in a substantial elevation in ROS levels and disruption of MMP. Importantly, this combination also exhibited cytotoxic effects in a non-malignant thyroid epithelial cell line (Nthy-ori 3-1), though to a lesser extent. Conclusions: These findings demonstrate that PIO potentiates the antitumor activity of ICG–PDT by inducing oxidative stress and mitochondrial dysfunction. This in vitro approach suggests a rational, combinatorial strategy that merits further investigation in preclinical models of thyroid cancer.